You are here

  • Home
  • Archive
  • Volume 81, Issue 6
  • Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis

Article Text

Article menu

Download PDFPDF

Correspondence
Error in the dosage of Methotrexate in the EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis
Free
  1. Dennis Scheicht
  1. Clinic of Rheumatology, Krankenhaus Porz am Rhein gGmbH, Cologne 51149, Germany
  1. Correspondence to Dr Dennis Scheicht, Clinic of Rheumatology, Krankenhaus Porz am Rhein gGmbH, Cologne 51149, Germany; dscheicht{at}gmail.com

https://doi.org/10.1136/annrheumdis-2020-217041

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis (AAV)1 are a pillar in the treatment of patients with these diseases worldwide. Hence, it is of the utmost importance that information, especially dosing be correct and therefore reliable. More …

    View Full Text

    Linked Articles